A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia (VISTA)
Sponsor: Centers for Behavioral Health, LLC
This PHASE2 trial investigates Schizophrenia and is currently completed. Centers for Behavioral Health, LLC leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Feb 2019 — Sep 2019 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE2
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Behavioral Health, LLC
- Clinical Innovations
- Indiana University
- Innovative Clinical Research, Inc.
- Laureate Institute for Brain Research, Inc.
- Sheppard Pratt Health System
- Stanley Medical Research Institute
- University of California Riverside at C.I. Trials, Inc.-Inland Empire
- University of California, Los Angeles
- University of Kansas Medical Center
- University of Maryland
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .